Porphyria cutanea tarda in a patient with HIV-infection.
Several recent reports have described porphyria cutanea tarda (PCT) occurring in patients with HIV infection. Current evidence suggests that HIV infection may impair the hepatic cytochrome oxidase system, which could lead to an aberration in porphyrin metabolism and subsequently cause porphyria. We report a case of PCT in an HIV-infected patient who had multiple risk factors for this disorder.
Almehmi
Ammar
A
Dept. of Medicine, West Virginia University School of Medicine, Charleston Division, USA.
Deliri
Hamid
H
Szego
Gabriel G
GG
Teague
A Christin
AC
Pfister
Alfred K
AK
Martin
Shelda A
SA
D003576:Electron Transport Complex IV / Q000378:metabolism; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006679:HIV Seropositivity / Q000201:enzymology; D006801:Humans; D008099:Liver / Q000201:enzymology; D008875:Middle Aged; D017119:Porphyria Cutanea Tarda / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000201:enzymology; D012307:Risk Factors; D014575:Uroporphyrinogen Decarboxylase / Q000172:deficiency
D003576:Electron Transport Complex IV; D014575:Uroporphyrinogen Decarboxylase